Featured News

2

UC researchers develop new CPAP device

April 17, 2024

Researchers at the University of Cincinnati are developing a VortexPAP machine that takes advantage of vortex airflow technology. A preliminary clinical study with current CPAP users demonstrated that the VortexPAP can deliver the pressure levels that are used in the subjects’ CPAP therapy, but the mask is more comfortable to wear. It has a minimalistic design that is less intrusive and barely touches the patient’s face.

3

The next generation of care

April 15, 2024

University of Cincinnati student-led nonprofit organization Parkinson's Together takes a multidisciplinary approach to meeting the needs of patients with Parkinson's disease in their community. Now it's setting a model for student organizations across the country.

Debug Query for this

Latest News

2

UC researchers develop new CPAP device

April 17, 2024

Researchers at the University of Cincinnati are developing a VortexPAP machine that takes advantage of vortex airflow technology. A preliminary clinical study with current CPAP users demonstrated that the VortexPAP can deliver the pressure levels that are used in the subjects’ CPAP therapy, but the mask is more comfortable to wear. It has a minimalistic design that is less intrusive and barely touches the patient’s face.

3

The next generation of care

April 15, 2024

University of Cincinnati student-led nonprofit organization Parkinson's Together takes a multidisciplinary approach to meeting the needs of patients with Parkinson's disease in their community. Now it's setting a model for student organizations across the country.

7

MedCentral: Pros and cons of intermittent fasting on...

April 10, 2024

The University of Cincinnati's Richard Becker commented to MedCentral on a recent study that found people who limit their eating to an 8-hour period each day had a 91% greater risk of cardiovascular death than those who ate during a window of 12 to 16 hours.

8

Pulmonary arterial hypertension drug studied at UC receives FDA...

April 4, 2024

Clinical research conducted at the University of Cincinnati College of Medicine and UC Health played a role in the U.S. Food and Drug Administration's March 26 approval of WINREVAIR™ (sotatercept-csrk) for the treatment of pulmonary arterial hypertension (PAH) in adults.

12

Pharmacy Times: How AI, machine learning can benefit...

March 25, 2024

Pharmacy Times highlighted a presentation from the University of Cincinnati's Shawn Xiong discussing the potential for artificial intelligence and machine learning to bolster pharmaceutical development and research.

15

Global News Canada: Harm reduction vending machine now in...

March 20, 2024

The University of Cincinnati's Daniel Arendt spoke with Global News Canada about the benefits of free harm reduction vending machines being implemented in Hamilton County, Ohio, as a similar machine has been launched in Winnipeg, Manitoba, Canada.

Load More
Debug Query for this